Healthcare highlights Charles Stanley's top stocks

A number of healthcare stocks highlight Charles Stanley's top stock picks for February - with GlaxoSmithKine, Hikma Pharmaceuticals and Smith & Nephew all tipped to outperform.

Charles Stanley believes GSK's shares remain under-rated and says a series of initiatives implemented by new group CEO Andrew Witty will deliver a dividend yield in excess of 5%. It also says Hikma should follow impressive performance in 2009 with continued strong compound EPS growth over the next few years, justifying its rating. "Although Jordanian-based Hikma has been a long-time favourite of ours, we believe more lies in store in 2010," Charles Stanley says. "Specifically, the company occupies the number five position in MENA pharmaceuticals and due to its local roots and stron...